Importantly, ManS was produced by a noncanonical biogenesis mechanism: The ribonuclease RNase III, which usually cuts double-stranded RNA ... and secondary metabolic pathways, particularly ...

Importantly, ManS was produced by a noncanonical biogenesis mechanism: The ribonuclease RNase III, which usually cuts double-stranded RNA ... and secondary metabolic pathways, particularly ...

Regulatory Mechanism: ManS isoforms control multiple metabolic pathways, including glycan ... ManS was produced by a noncanonical biogenesis mechanism: The ribonuclease RNase III, which usually cuts ...

Figure 2 Simplified overview of the canonical and non-canonical miRNA biogenesis pathways. MiRNA generated by canonical pathway is transcribed by RNA polymerase II to a primary transcript called ...

UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA ...

RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA ...